"The prescription co-payment programs run by Bristol-Myers Squibb (BMS) will now begin with the first dollar a person pays a pharmacy or mail-order service for his or her Reyataz (atazanavir) or Sustiva (efavirenz) prescriptions. Previously, people with HIV had to cover the first $50 of their co-pay before the BMS programs began to contribute."
Read more in POZ, December 18, 2009.
0 comments:
Post a Comment